228 related articles for article (PubMed ID: 24962166)
21. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
[TBL] [Abstract][Full Text] [Related]
22. Aberrant Methylation of APAF-1 Gene in Acute Myeloid Leukemia Patients.
Rostami S; Nadali F; Alibakhshi R; Zaker F; Nasiri N; Payandeh M; Chahardouli B; Maleki A
Int J Hematol Oncol Stem Cell Res; 2017 Jul; 11(3):225-230. PubMed ID: 28989589
[No Abstract] [Full Text] [Related]
23. Hypermethylation of the FANCC and FANCL promoter regions in sporadic acute leukaemia.
Hess CJ; Ameziane N; Schuurhuis GJ; Errami A; Denkers F; Kaspers GJ; Cloos J; Joenje H; Reinhardt D; Ossenkoppele GJ; Zwaan CM; Waisfisz Q
Cell Oncol; 2008; 30(4):299-306. PubMed ID: 18607065
[TBL] [Abstract][Full Text] [Related]
24. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
[TBL] [Abstract][Full Text] [Related]
25. TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population.
Yao H; Duan M; Lin L; Wu C; Fu X; Wang H; Guo L; Chen W; Huang L; Liu D; Rao R; Wang S; Ding Y
Oncotarget; 2017 Mar; 8(11):18337-18347. PubMed ID: 28407691
[TBL] [Abstract][Full Text] [Related]
26. Protein tyrosine phosphatases receptor type D is a potential tumour suppressor gene inactivated by deoxyribonucleic acid methylation in paediatric acute myeloid leukaemia.
Song L; Jiang W; Liu W; Ji JH; Shi TF; Zhang J; Xia CQ
Acta Paediatr; 2016 Mar; 105(3):e132-41. PubMed ID: 26607758
[TBL] [Abstract][Full Text] [Related]
27. DOK6 promoter methylation serves as a potential biomarker affecting prognosis in de novo acute myeloid leukemia.
Sun GK; Tang LJ; Zhou JD; Xu ZJ; Yang L; Yuan Q; Ma JC; Liu XH; Lin J; Qian J; Yao DM
Cancer Med; 2019 Oct; 8(14):6393-6402. PubMed ID: 31486300
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic Silencing of Eyes Absent 4 Gene by Acute Myeloid Leukemia 1-Eight-twenty-one Oncoprotein Contributes to Leukemogenesis in t(8;21) Acute Myeloid Leukemia.
Huang S; Jiang MM; Chen GF; Qian K; Gao HH; Guan W; Shi JL; Liu AQ; Liu J; Wang BH; Li YH; Yu L
Chin Med J (Engl); 2016 Jun; 129(11):1355-62. PubMed ID: 27231175
[TBL] [Abstract][Full Text] [Related]
29. The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia.
Agrawal S; Hofmann WK; Tidow N; Ehrich M; van den Boom D; Koschmieder S; Berdel WE; Serve H; Müller-Tidow C
Blood; 2007 May; 109(9):3895-905. PubMed ID: 17234736
[TBL] [Abstract][Full Text] [Related]
30. KG-1 and KG-1a model the p15 CpG island methylation observed in acute myeloid leukemia patients.
Dodge JE; Munson C; List AF
Leuk Res; 2001 Oct; 25(10):917-25. PubMed ID: 11532526
[TBL] [Abstract][Full Text] [Related]
31. Promoter methylation and expression of DNA repair genes hMLH1 and MGMT in acute myeloid leukemia.
Lenz G; Hutter G; Hiddemann W; Dreyling M
Ann Hematol; 2004 Oct; 83(10):628-33. PubMed ID: 15309527
[TBL] [Abstract][Full Text] [Related]
32. Methylation of CTNNA1 promoter: frequent but not an adverse prognostic factor in acute myeloid leukemia.
Chen XX; Lin J; Qian J; Qian W; Yang J; Ma JC; Deng ZQ; An C; Tang CY; Qian Z; Liu Q
Leuk Res; 2014 May; 38(5):613-8. PubMed ID: 24685333
[TBL] [Abstract][Full Text] [Related]
33. [Promoter methylation status of hPer3 gene in AML patients and the in vitro effect of decitabine on the status].
Wang YK; Zhou JH; Zhou SQ; Fang GA; Li YW; Qiu L; Yang XC; Liu XG
Zhonghua Xue Ye Xue Za Zhi; 2011 May; 32(5):317-21. PubMed ID: 21729600
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic modifications of splicing factor genes in myelodysplastic syndromes and acute myeloid leukemia.
Wong JJ; Lau KA; Pinello N; Rasko JE
Cancer Sci; 2014 Nov; 105(11):1457-63. PubMed ID: 25220401
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic inactivation of the hsa-miR-203 in haematological malignancies.
Chim CS; Wong KY; Leung CY; Chung LP; Hui PK; Chan SY; Yu L
J Cell Mol Med; 2011 Dec; 15(12):2760-7. PubMed ID: 21323860
[TBL] [Abstract][Full Text] [Related]
36. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
[TBL] [Abstract][Full Text] [Related]
37. [Expression of TFPI-2 gene and its promoter methylation in acute myeloid leukemia].
Shao LL; Fan J; Wang R; Feng LL; Zhen CQ; Sui XH; Li Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):920-6. PubMed ID: 25130804
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA 34b inhibits cell proliferation in pediatric acute myeloid leukemia via regulating LDHA.
Qi HX; Cao Q; Zhou GP; Sun XZ; Zhou WD; Hong Z; Hu J; Juan CX; Li S; Kuai WX
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5351-5359. PubMed ID: 31298387
[TBL] [Abstract][Full Text] [Related]
39. Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia.
Yao DM; Qian J; Lin J; Wang YL; Chen Q; Qian Z; Li Y; Wang CZ; Yang J
Leuk Res; 2011 Jul; 35(7):957-60. PubMed ID: 21106240
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic regulation of the non-canonical Wnt pathway in acute myeloid leukemia.
Martín V; Valencia A; Agirre X; Cervera J; San Jose-Eneriz E; Vilas-Zornoza A; Rodriguez-Otero P; Sanz MA; Herrera C; Torres A; Prosper F; Román-Gómez J
Cancer Sci; 2010 Feb; 101(2):425-32. PubMed ID: 19874313
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
